AIDS 2018 – 22nd International AIDS Conference

The International AIDS Conference is the largest conference on any global health or development issue in the world. First convened during the peak of the epidemic in 1985, it continues to provide a unique forum for the intersection of science, advocacy, and human rights – leaving behind lasting legacies in each host country.

The 22nd International AIDS Conference (AIDS 2018) will be hosted in Amsterdam, Netherlands on 23-27 July in 2018 under the theme – ‘Breaking Barriers, Building Bridges.’

Registration opens on 1 December 2017

HIV drug resistance now high enough to trigger a change in first-line treatment in eastern and southern Africa

HIV drug resistance is increasing rapidly in southern and eastern Africa and Latin America and, as a result, it may soon be necessary to change the recommended first-line antiretroviral drug regimen in many countries to integrase inhibitor-based treatment, according to an analysis published in The Lancet Infectious Diseases on 30 November.



12th INTEREST Conference (29 May – 1 June 2018) – Abstract submission now open

The 12th INTEREST Conference (known as the ‘African CROI’) will take place from 29 May – 1 June 2018 in Kigali, Rwanda.  The Conference brings together scientists involved in HIV treatment, pathogenesis, and prevention research in Africa to share pivotal findings, promote collaboration, and transfer experiences across several fields and many continents. The conference will showcase cutting-edge knowledge in the diagnosis and treatment of HIV and the prevention of the HIV-1 infection. Additionally, it will continue to foster building a community of African physicians and scientists to facilitate the implementation of local solutions for the management of patients living with HIV-1 infection and for the prevention of HIV transmission.

Abstracts are invited on the following topics: Continue reading “12th INTEREST Conference (29 May – 1 June 2018) – Abstract submission now open”

PLOS Collections – Advances in HIV Prevention, Treatment and Cure

HIV infection continues to pose a critical risk to health in many countries. UNAIDS estimates that as of 2016 the total HIV-infected population was 36.7 million, including 1.8 million people newly infected that year. Although some 19.5 million people are receiving antiretroviral treatment, a substantial treatment gap leaves many millions of people at risk of AIDS-related diseases and, if unaware of their status, likely to infect others. Research is seeking new approaches to prevent, treat, and ultimately cure HIV infection.

World AIDS Day 2017: Everybody counts

World AIDS Day is 1st December each year, an opportunity for people worldwide to unite in the fight against HIV, show their support for people living with HIV and to commemorate people who have died.

In 2015, global leaders signed up to the Sustainable Development Goals, with the aim to achieve universal health coverage (UHC) by 2030. The UHC framework now lies at the centre of all health programmes.

To complement the global World AIDS Day 2017 campaign which promotes the theme “Right to health”, the World Health Organization will highlight the need for all 36.7 million people living with HIV and those who are vulnerable and affected by the epidemic, to reach the goal of universal health coverage.

Under the slogan “Everybody counts”, Continue reading “World AIDS Day 2017: Everybody counts”

The IeDEA All-Africa Meeting – Kigali, Rwanda, November 5-6

IeDEA Central Africa led an all-Africa meeting to discuss how the IeDEA consortium could enhance “treat-all” implementation of universal HIV testing, treatment, retention, and virologic suppression across sub-Saharan Africa. Supported by an R13 from NIAID, the meeting brought together 200 participants to hear about Rwanda’s experience implementing universal HIV treatment, work on prioritizing research questions around the 90-90-90 cascade, develop strategies for how to integrate multi-disciplinary health services, and improve engagement with key populations. Overarching goals discussed included how to measure the impact of treat-all-related policy changes on HIV testing and treatment cascades, while exploring potential threats to long-term retention, including patients developing advanced HIV disease after returning to care following interruptions (“churn”). Continue reading “The IeDEA All-Africa Meeting – Kigali, Rwanda, November 5-6”